-
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts
Source: Buzz FX / 12 Jan 2025 01:40:16 America/Chicago
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of EyePoint Pharmaceuticals, Inc.
Read more...